General Admission
This ticket is strictly for therapeutic developers, pharma, gov/regulators, academics, and non-profits.
- Access to all content tracks (2 days)
- Networking opportunities across the event
- Daily breakfast & lunch included
- VIP Benefits
Apply to attend – Only 500 passes available
Attendance at Advanced Therapies Europe 2025 is limited to just 500 qualified delegates. Whether you're driving investment, scaling manufacturing, or building your next therapeutic breakthrough, your experience will be tailored, targeted, and designed for maximum impact.
Super Early Bird - SOLD OUT!
Early Bird - SOLD OUT!
Standard Pricing Available — apply now to secure your place at Europe’s premier cell and gene therapy event.
This ticket is strictly for therapeutic developers, pharma, gov/regulators, academics, and non-profits.
This ticket best for CDMOs, CROs, service providers, consultants, and solution providers supporting the advanced therapies sector.
This ticket is strictly for startups. *Subject to approval
This ticket is strictly for investors.
This ticket is for senior executives, investors, and industry leaders looking for an exclusive event experience.
Download the 2025 attendee list